Radiation Oncologist: Michael Toblyn, MD | Loyola Medicine

Michael Tomblyn, MD

Radiation Oncology

Associate Professor

Languages Spoken


Clinical Expertise

  • Brachytherapy
  • Breast Cancer
  • Gastrointestinal Cancer
  • HDR/LDR Brachytherapy
  • Intensity Modulated Radiotherapy (IMRT)
  • Lung Cancer
  • Prostate Cancer
  • Stereotactic Body Radiation Therapy
  • Testicular Cancer

About Dr. Tomblyn


Medical Education

Medical School
Rush Medical College

Board Certification

American Board of Radiology, Radiation Oncology


  • Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial., Seider, MJ; Pugh, SL; Langer, C; Wyatt, G; Demas, W; Rashtian, A; Clausen, CL; Derdel, JD; Cleary, SF; Peters, CA; Ramalingam, A; Clarkson, JE; Tomblyn, M; Rabinovitch, RA; Kachnic, LA; Berk, LB, ANNALS OF NUCLEAR MEDICINE
  • Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma. Abuodeh, Y; Ahmed, K; Echevarria, M; Naghavi, A; Grass, GD; Robinson, TJ; Tomblyn, M; Shah, B; Chavez, J; Bello, C; El-Haddad, G; Harrison, L; Kim, S, Therapeutic advances in hematology
  • Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory aggressive non-Hodgkin lymphoma., Witzig, TE; Tomblyn, MB; Misleh, JG; Kio, EA; Sharkey, RM; Wegener, WA; Goldenberg, DM, Haematologica
View All ResearchShow Less